Your session is about to expire
← Back to Search
Group Psychotherapy for Cancer Patients
Phase 3
Waitlist Available
Led By William Breitbart, MD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
All patients with stage IV solid tumor cancers; or Stage III solid tumor cancers (excluding breast and prostate cancer) who are receiving ambulatory care at Memorial Sloan-Kettering Cancer Center
Able to communicate with an English speaking therapist
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 weeks
Awards & highlights
Study Summary
This trial is comparing two types of group counseling for cancer patients - Meaning-Centered and Supportive. The goal is to see which is more beneficial for patients in terms of coping with their illness.
Who is the study for?
This trial is for English-speaking adults over 21 with advanced stage IV solid tumor cancers, or certain stage III cancers, who are outpatients at Memorial Sloan-Kettering Cancer Center. It's not suitable for those with severe psychiatric issues, cognitive impairments (as indicated by MMSE scores below 20), or physical limitations that prevent participation in group therapy.Check my eligibility
What is being tested?
The study compares two types of group counseling for cancer patients: Meaning-Centered Psychotherapy aimed at finding purpose despite cancer and Supportive Psychotherapy providing a space to express feelings and gain support from peers. The effectiveness of these approaches in coping with the emotional challenges of cancer will be evaluated.See study design
What are the potential side effects?
While traditional side effects associated with medical treatments may not apply here, participants might experience emotional discomfort or distress during discussions about their illness and its impact on their lives within the psychotherapy sessions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have stage IV cancer or stage III cancer (not breast or prostate) and am treated at Memorial Sloan-Kettering.
Select...
I can communicate with an English-speaking therapist.
Select...
I am 21 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 16 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
The to be measured include measures of spiritual well-being (meaning) and psychological distress (depression, hopelessness, optimism quality of life).
Secondary outcome measures
To examine clinical and demographic variables that may correspond to differential responses to Meaning-Centered Group Psychotherapy.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: 1Experimental Treatment1 Intervention
Meaning Centered Group Psychotherapy (MCGP)
Group II: 2Active Control1 Intervention
standardized Supportive Group Psychotherapy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Meaning Centered Group Psychotherapy
2007
Completed Phase 3
~260
Find a Location
Who is running the clinical trial?
Memorial Sloan Kettering Cancer CenterLead Sponsor
1,936 Previous Clinical Trials
588,644 Total Patients Enrolled
Fordham UniversityOTHER
19 Previous Clinical Trials
3,804 Total Patients Enrolled
1 Trials studying Palliative Care
80 Patients Enrolled for Palliative Care
William Breitbart, MDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
7 Previous Clinical Trials
1,744 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have stage IV cancer or stage III cancer (not breast or prostate) and am treated at Memorial Sloan-Kettering.I am too ill to attend group therapy sessions.I can communicate with an English-speaking therapist.I am 21 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: 1
- Group 2: 2
Awards:
This trial has 2 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this trial currently recruiting new participants?
"Data from clinicaltrials.gov suggests that this study is no longer looking for participants. This information was originally posted on 6/1/2007 and was last edited on 8/9/2022. However, there are 43 other trials currently underway that may be of interest."
Answered by AI
Are there any potential risks that come with participating in Meaning Centered Group Psychotherapy?
"There is some evidence to support the efficacy of Meaning Centered Group Psychotherapy, as well as multiple rounds of data affirming its safety. Therefore, it receives a score of 3 on our 1-3 scale."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger